DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.
Internucleosomal DNA fragmentation following the activation of endonucleases is the common end point of apoptosis. DNase I, a Ca(2+) / Mg(2+)-dependent endonuclease ubiquitously expressed in mammalian tissues, is believed to play a role in this process. To analyze the in vivo function of this enzyme in human cells, we have generated a cell line with targeted disruption of the DNase I gene, as well as several stable cell lines which overexpress the DNase I gene. Inactivation of the human DNase I gene was obtained in the Jurkat T cell clone JA3, characterized by high susceptibility to apoptotic cell death induced by pharmacological stimuli. JA3 cells, after disruption of the DNase I gene, became resistant to apoptotic stimuli. DNase I was overexpressed in the human cell lines JA3, K562 (erythroleukemia), M 14 (melanoma) and CEM (T cell lymphoma). Remarkably, stable overexpression of DNase I gene resulted in accelerated apoptosis in JA3 cells and induced apoptosis in K562, CEM and M14 cell lines, which are otherwise resistant to internucleosomal DNA degradation following pharmacological stimuli. Our study provides the first in vivo evidence that DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis.
Oliveri
M
M
Department of Experimental Medicine, University of Genova, Genova, Italy.
Daga
A
A
Cantoni
C
C
Lunardi
C
C
Millo
R
R
Puccetti
A
A
D017209:Apoptosis / Q000187:drug effects*; D002467:Cell Nucleus / Q000648:ultrastructure; D002470:Cell Survival / Q000187:drug effects; D003513:Cycloheximide / Q000494:pharmacology; D004247:DNA / Q000378:metabolism*; D053938:DNA Fragmentation / Q000187:drug effects; D003609:Dactinomycin / Q000494:pharmacology; D003850:Deoxyribonuclease I / Q000235:genetics / Q000502:physiology*; D005047:Etoposide / Q000494:pharmacology; D018390:Gene Targeting; D006801:Humans; D019169:Jurkat Cells; D007700:Kinetics; D009707:Nucleosomes / Q000378:metabolism*; D017239:Paclitaxel / Q000494:pharmacology; D014162:Transfection; D014407:Tumor Cells, Cultured; D019014:fas Receptor / Q000378:metabolism
D009707:Nucleosomes; D019014:fas Receptor; D003609:Dactinomycin; D005047:Etoposide; D004247:DNA; D003513:Cycloheximide; D003850:Deoxyribonuclease I; D017239:Paclitaxel